- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens signs $250 million GPO deal
Siemens Medical Systems has entered into a five-year purchasing agreement with regional group purchasing organization Shared Services Healthcare. Under the agreement, Iselin, NJ-based Siemens becomes the sole medical device provider to Atlanta-based SSH.
Siemens Medical Systems has entered into a five-year purchasing agreement with regional group purchasing organization Shared Services Healthcare. Under the agreement, Iselin, NJ-based Siemens becomes the sole medical device provider to Atlanta-based SSH. SSH members will now be able to purchase all Siemens imaging modalities, oncology treatment products, patient monitors, ventilators, and anesthesia equipment at discount prices. Siemens expects the agreement to generate more than $250 million in revenues.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
